Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial

Preventive Medicine

Volumn 91, Issue , 2016, Pages 172-179

  Lau, Cathrine J ^a   Pisinger, Charlotta ^a,b   Husemoen, Lise Lotte N ^a   Jacobsen, Rikke Kart ^a   Linneberg, Allan ^a,b,c   Jørgensen, Torben ^a,b,d   Glümer, Charlotte ^a,d  

^a Research Centre for Prevention and Health   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Rigshospitalet   (Denmark)

^d AALBORG UNIVERSITY   (Denmark)

Author keywords

Incidence of diabetes; Lifestyle intervention; Population level; Randomised trial; Screening

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DANE (PEOPLE); DIABETES MELLITUS; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MALE; MASS SCREENING; MIDDLE AGED; NUTRITIONAL COUNSELING; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING CESSATION; WEIGHT REDUCTION; COUNSELING; DENMARK; LIFESTYLE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADULT; COUNSELING; DENMARK; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; LIFE STYLE; MALE; MASS SCREENING; MIDDLE AGED; RISK FACTORS;

EID: 84983423246     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2016.08.016     Document Type: Article

References (59)

1. Aguirre, F., Brown, A., Cho, N.H., et al. IDF diabetes atlas sixth edition. Secondary IDF Diabetes Atlas, sixth ed., 2013 https://www.idf.org/sites/default/files/EN_6E_Atlas_Exec_Sum_1.pdf.
2. American Diabetes Association, Standards of medical care in diabetes—2013. Diabetes Care 36:Suppl. 1 (2013), S11–S66.
3. Andersen, P.K., Geskus, R.B., de Witte, T., et al. Competing risks in epidemiology: possibilities and pitfalls. Int. J. Epidemiol. 41:3 (2012), 861–870.
4. Andersson, E.A., Allin, K.H., Sandholt, C.H., et al. Genetic risk score of 46 type 2 diabetes risk variants associates with changes in plasma glucose and estimates of pancreatic β-cell function over 5 years of follow-up. Diabetes 62:10 (2013), 3610–3617.
5. Bandura, A., Cliffs, E., (eds.) Social Foundations of Thought and Action, a Social Cognitive Theory, 1986, Prentice-Hall, N.J.
6. Baumann, S., Toft, U., Aadahl, M., et al. The long-term effect of screening and lifestyle counseling on changes in physical activity and diet: the Inter99 study – a randomized controlled trial. Int. J. Behav. Nutr. Phys. Act., 12, 2015, 33.
7. Bender, A.M., Jørgensen, T., Pisinger, C., Is self-selection the main driver of positive interpretations of general health checks? The Inter99 randomized trial. Prev. Med. 81 (2015), 42–48.
8. Carstensen, B., Kristensen, J.K., Ottosen, P., et al. The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia 51:12 (2008), 2187–2196.
9. Carstensen, B., Kristensen, J.K., Marcussen, M.M., et al. The National Diabetes Register. Scand. J. Public Health 39:7 Suppl (2011), 58–61.
10. Chaloupka, F.J., Yurekli, A., Fong, G.T., Tobacco taxes as a tobacco control strategy. Tob. Control. 21:2 (2012), 172–180.
11. Dunkley, A.J., Bodicoat, D.H., Greaves, C.J., et al. Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis. Diabetes Care 37:4 (2014), 922–933.
12. Echouffo-Tcheugui, J.B., Ali, M.K., Griffin, S.J., et al. Screening for type 2 diabetes and dysglycemia. Epidemiol. Rev. 33 (2011), 63–87.
13. Eriksson, K.F., Lindgärde, F., No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmö Preventive Trial with diet and exercise. Diabetologia 41:9 (1998), 1010–1016.
14. Franco, M., Ordunez, P., Caballero, B., et al. Impact of energy intake, physical activity, and population-wide weight loss on cardiovascular disease and diabetes mortality in Cuba, 1980–2005. Am. J. Epidemiol. 166:12 (2007), 1374–1380.
15. Gillies, C.L., Abrams, K.R., Lambert, P.C., et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ, 334(7588), 2007, 299.
16. Green, A., Sortso, C., Jensen, P.B., et al. Validation of the Danish national diabetes register. Clin. Epidemiol. 7 (2015), 5–15.
17. Griffin, S.J., Borch-Johnsen, K., Davies, M.J., et al. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet 378:9786 (2011), 156–167.
18. Harris, M.I., Klein, R., Welborn, T.A., et al. Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diabetes Care 15:7 (1992), 815–819.
19. Herman, W.H., Ye, W., Griffin, S.J., et al. Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the Anglo-Danish-Dutch study of intensive treatment in people with screen-detected diabetes in primary care (ADDITION-Europe). Diabetes Care 38:8 (2015), 1449–1455.
20. Hill, J.O., Galloway, J.M., Goley, A., et al. Scientific statement: socioecological determinants of prediabetes and type 2 diabetes. Diabetes Care 36:8 (2013), 2430–2439.
21. International Diabetes Federation, IDF diabetes atlas sixth edition: key findings secondary IDF diabetes atlas sixth edition: key findings, 2014.
22. Janz, N.K., Becker, M.H., The Health Belief Model: a decade later. Health Educ. Q. 11:1 (1984), 1–47.
23. Jørgensen, T., Borch-Johnsen, K., Thomsen, T.F., et al. A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur. J. Cardiovasc. Prev. Rehabil. 10:5 (2003), 377–386.
24. Jørgensen, T., Capewell, S., Prescott, E., et al. Population-level changes to promote cardiovascular health. Eur. J. Prev. Cardiol. 20:3 (2013), 409–421.
25. Jørgensen, T., Jacobsen, R.K., Toft, U., et al. Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ, 348, 2014, g3617.
26. Kahn, R., Davidson, M.B., The reality of type 2 diabetes prevention. Diabetes Care 37:4 (2014), 943–949.
27. Kildemoes, H.W., Sorensen, H.T., Hallas, J., The Danish National Prescription Registry. Scand. J. Public Health 39:7 Suppl (2011), 38–41.
28. Knowler, W.C., Barrett-Connor, E., Fowler, S.E., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346:6 (2002), 393–403.
29. Knowler, W.C., Fowler, S.E., Hamman, R.F., et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374:9702 (2009), 1677–1686.
30. Krogsbøll, L.T., Jørgensen, K.J., Grønhøj Larsen, C., et al. General health checks in adults for reducing morbidity and mortality from disease. Cochrane Database Syst. Rev., 10, 2012, CD009009.
31. Lau, C., Vistisen, D., Toft, U., et al. The effects of adding group-based lifestyle counselling to individual counselling on changes in plasma glucose levels in a randomized controlled trial: the Inter99 study. Diabetes Metab. 37:6 (2011), 546–552.
32. Lauritzen, T., Sandbaek, A., Borch-Johnsen, K., General health checks may work. BMJ, 349, 2014, g4697.
33. Li, G., Zhang, P., Wang, J., et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 371:9626 (2008), 1783–1789.
34. Li, G., Zhang, P., Wang, J., et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diab. Endocrinol. 2:6 (2014), 474–480.
35. Lindström, J., Peltonen, M., Eriksson, J.G., et al. Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). Diabetologia 56:2 (2013), 284–293.
36. Lynge, E., Sandegaard, J.L., Rebolj, M., The Danish National Patient Register. Scand. J. Public Health 39:7 Suppl (2011), 30–33.
37. Miller, W.R., Motivational interviewing with problem drinkers. Behav. Cogn. Psychother. 11:02 (1983), 147–172.
38. Mozaffarian, D., Afshin, A., Benowitz, N.L., et al. Population approaches to improve diet, physical activity, and smoking habits: a scientific statement from the American Heart Association. Circulation 126:12 (2012), 1514–1563.
39. National Institute for Health and Care Excellence (NICE), Preventing type 2 diabetes: risk identification and interventions for individuals at high risk. Secondary preventing type 2 diabetes: risk identification and interventions for individuals at high risk, 2012.
40. Ng, M., Fleming, T., Robinson, M., et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384:9945 (2014), 766–781.
41. Norris, S.L., Kansagara, D., Bougatsos, C., et al. Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force. Ann. Intern. Med. 148:11 (2008), 855–868.
42. Palermo, A., Maggi, D., Maurizi, A.R., et al. Prevention of type 2 diabetes mellitus: is it feasible?. Diabetes Metab. Res. Rev. 30:S1 (2014), 4–12.
43. Pedersen, C.B., The Danish Civil Registration System. Scand. J. Public Health 39:7 Suppl (2011), 22–25.
44. Pisinger, C., Vestbo, J., Borch-Johnsen, K., et al. Smoking cessation intervention in a large randomised population-based study. The Inter99 study. Prev. Med. 40:3 (2005), 285–292.
45. Pottie, K., Jaramillo, A., Lewin, G., et al. Recommendations on screening for type 2 diabetes in adults. CMAJ 184:15 (2012), 1687–1696.
46. Prochaska, J.O., DiClemente, C.C., Norcross, J.C., In search of how people change: applications to addictive behaviors. Marlatt, A.G., VandenBos, G.R., (eds.) Addictive Behaviors: Readings on Etiology, Prevention, and Treatment, 1997, American Psychological Association, Washington DC, 671–696.
47. Rahman, M., Simmons, R.K., Hennings, S.H., et al. How much does screening bring forward the diagnosis of type 2 diabetes and reduce complications? Twelve year follow-up of the Ely cohort. Diabetologia 55:6 (2012), 1651–1659.
48. Sahl Andersen, J., De Fine, O.N., Krasnik, A., The Danish National Health Service Register. Scand. J. Public Health 39:7 suppl (2011), 34–37.
49. Simmons, R.K., Echouffo-Tcheugui, J.B., Sharp, S.J., Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet 380:9855 (2012), 1741–1748.
50. The Diabetes Forum, Diabetes screening test. Secondary diabetes screening test, 2015.
51. Thomsen, T.F., Davidsen, M., Ibsen, H., et al. A new method for CHD prediction and prevention based on regional risk scores and randomized clinical trials; PRECARD and the Copenhagen Risk Score. J. Cardiovasc. Risk 8:5 (2001), 291–297.
52. Toft, U., Kristoffersen, L., Ladelund, S., et al. The impact of a population-based multi-factorial lifestyle intervention on changes in long-term dietary habits: the Inter99 study. Prev. Med. 47:4 (2008), 378–383.
53. Tuomilehto, J., Lindström, J., Eriksson, J.G., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344:18 (2001), 1343–1350.
54. U.S. Preventive Services, Draft recommendation statement: abnormal glucose and type 2 diabetes mellitus in adults: screening. Secondary draft recommendation statement: abnormal glucose and type 2 diabetes mellitus in adults: screening, 2014.
55. United Nations, High-level Meeting on the comprehensive review and assessment of the progress achieved in the prevention and control of non - communicable diseases (NCDs) 10 and 11 July 2014. Secondary High-level Meeting on the comprehensive review and assessment of the progress achieved in the prevention and control of non - communicable diseases (NCDs) 10 and 11 July 2014, 2014.
56. von Huth Smith, S.L., Ladelund, S., Borch-Johnsen, K., et al. A randomized multifactorial intervention study for prevention of ischaemic heart disease (Inter99): the long-term effect on physical activity. Scand. J. Public Health 36:4 (2008), 380–388.
57. WHO, Global action plan for the prevention and control of NCDs 2013–2020. Secondary Global Action Plan for the Prevention and Control of NCDs 2013–2020, 2014 http://www.who.int/nmh/events/ncd_action_plan/en/.
58. Williams, H.C., Burden-Teh, E., Nunn, A.J., What is a pragmatic clinical trial?. J. Invest. Dermatol., 135(6), 2015, e33.
59. Yoon, U., Kwok, L.L., Magkidis, A., Efficacy of lifestyle interventions in reducing diabetes incidence in patients with impaired glucose tolerance: a systematic review of randomized controlled trials. Metabolism 62:2 (2013), 303–314.